Early Complications of Ventriculoperitoneal Shunt in Pediatric Patients With Hydrocephalus

Bilal Khan1, Saima Hamayun2, Usman Haqqani3

  • 1Neurosurgery, Lady Reading Hospital-Medical Teaching Institutions (MTI), Peshawar, PAK.

Cureus
|March 31, 2021
PubMed

Insights

Ventriculoperitoneal shunts (VPS) are common for pediatric hydrocephalus (HDC), but nearly 20% of patients experience early complications like blockage or infection. Careful monitoring post-surgery is crucial for managing these risks.

Area of Science:

  • Neurosurgery
  • Pediatric Surgery
  • Medical Device Complications

Background:

  • Ventriculoperitoneal shunt (VPS) is the primary treatment for pediatric hydrocephalus (HDC).
  • VPS procedures are associated with significant early post-operative complications, increasing patient morbidity.
  • Understanding the incidence and types of early complications is vital for improving patient outcomes.

Purpose of the Study:

  • To investigate the early post-operative complications of VPS in pediatric hydrocephalus patients.
  • To determine the incidence and timing of complications within the first 30 days after shunt placement.
  • To identify common complications associated with VPS in this population.

Main Methods:

  • A descriptive study involving 151 pediatric patients (<12 years) undergoing their first VPS for hydrocephalus.
  • Data collected included patient demographics, hydrocephalus etiology, surgery type, and post-operative complications over a 30-day follow-up period.
  • Statistical analysis was performed using SPSS version 19, with results presented in charts and tables.

Main Results:

  • Complications were observed in 19.87% (30/151) of patients within 30 days post-surgery.
  • The mean time to complication onset was 9.10 ± 1.69 days.
  • Common early complications included shunt blockage, infections, and abdominal wound issues.

Conclusions:

  • Ventriculoperitoneal shunting, while essential for hydrocephalus treatment, carries a notable risk of early complications.
  • Approximately one in five pediatric patients experience complications shortly after VPS surgery.
  • Shunt malfunction, infection, and wound-related problems are the most frequent early adverse events requiring attention.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
266
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
207
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
104
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
109